CODX – Co-Diagnostics, Inc.
CODX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
2.77
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.21
EPS Last/This Y
23.1
EPS This/Next Y
0.15
Price
5.07
Target Price
45
Analyst Recom
3
Performance Q
118.77
Upside
-7,282.1%
Beta
1.52
Ticker: CODX
21 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-24 | CODX | 1.65 | N/A | N/A | 0 |
| 2026-04-27 | CODX | 1.67 | N/A | N/A | 0 |
| 2026-04-28 | CODX | 1.59 | N/A | N/A | 0 |
| 2026-04-29 | CODX | 1.537 | N/A | N/A | 0 |
| 2026-04-30 | CODX | 1.565 | N/A | N/A | 0 |
| 2026-05-01 | CODX | 1.56 | N/A | N/A | 0 |
| 2026-05-04 | CODX | 1.585 | N/A | N/A | 0 |
| 2026-05-05 | CODX | 1.61 | N/A | N/A | 0 |
| 2026-05-06 | CODX | 1.61 | N/A | N/A | 0 |
| 2026-05-07 | CODX | 1.95 | N/A | N/A | 0 |
| 2026-05-08 | CODX | 2.53 | N/A | N/A | 0 |
| 2026-05-11 | CODX | 1.895 | N/A | N/A | 0 |
| 2026-05-12 | CODX | 1.73 | N/A | N/A | 0 |
| 2026-05-13 | CODX | 1.56 | N/A | N/A | 0 |
| 2026-05-14 | CODX | 1.64 | N/A | N/A | 0 |
| 2026-05-15 | CODX | 1.28 | N/A | N/A | 0 |
| 2026-05-18 | CODX | 1.35 | N/A | N/A | 0 |
| 2026-05-19 | CODX | 2 | N/A | N/A | 0 |
| 2026-05-20 | CODX | 2.38 | N/A | N/A | 0 |
| 2026-05-21 | CODX | 3.7 | N/A | N/A | 0 |
| 2026-05-22 | CODX | 4.95 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-24 | CODX | 1.68 | 51.4 | 554.7 | -12.15 |
| 2026-04-27 | CODX | 1.65 | 51.4 | 538.3 | -12.15 |
| 2026-04-28 | CODX | 1.60 | 51.4 | 667.3 | -12.15 |
| 2026-04-30 | CODX | 1.55 | 51.4 | 644.6 | -12.15 |
| 2026-05-01 | CODX | 1.56 | 51.4 | 644.6 | -12.15 |
| 2026-05-04 | CODX | 1.58 | 51.4 | 636.6 | -12.15 |
| 2026-05-05 | CODX | 1.61 | 51.4 | 640.8 | -12.15 |
| 2026-05-06 | CODX | 1.64 | 51.4 | 635.1 | -12.15 |
| 2026-05-07 | CODX | 1.92 | 51.4 | 538.7 | -12.15 |
| 2026-05-08 | CODX | 2.53 | 51.4 | 142.9 | -12.15 |
| 2026-05-11 | CODX | 1.89 | 51.4 | 433.6 | -12.15 |
| 2026-05-12 | CODX | 1.72 | 51.4 | 593.5 | -12.15 |
| 2026-05-13 | CODX | 1.58 | 51.4 | 585.4 | -12.15 |
| 2026-05-14 | CODX | 1.64 | 51.4 | 629.2 | -12.15 |
| 2026-05-15 | CODX | 1.29 | 51.4 | 780.3 | -12.15 |
| 2026-05-18 | CODX | 1.35 | 51.4 | - | -12.15 |
| 2026-05-19 | CODX | 1.98 | 51.4 | - | -12.15 |
| 2026-05-20 | CODX | 2.42 | 57.2 | - | -12.15 |
| 2026-05-21 | CODX | 3.77 | 57.2 | - | -12.15 |
| 2026-05-22 | CODX | 5.07 | 57.2 | - | -12.15 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-24 | CODX | 0.00 | -5.12 | 5.13 |
| 2026-04-27 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-04-28 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-04-29 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-04-30 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-01 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-04 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-05 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-06 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-07 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-08 | CODX | 0.00 | -5.12 | 1.39 |
| 2026-05-11 | CODX | 0.00 | -5.19 | 1.39 |
| 2026-05-12 | CODX | 0.00 | -5.19 | 2.88 |
| 2026-05-13 | CODX | 0.00 | -5.19 | 2.88 |
| 2026-05-14 | CODX | 0.00 | -5.19 | 2.88 |
| 2026-05-15 | CODX | 0.00 | -5.19 | 2.88 |
| 2026-05-18 | CODX | 0.00 | -0.17 | 2.77 |
| 2026-05-19 | CODX | 0.00 | -0.17 | 2.77 |
| 2026-05-20 | CODX | 0.00 | -0.17 | 2.77 |
| 2026-05-21 | CODX | 0.00 | -0.17 | 2.77 |
| 2026-05-22 | CODX | 0.00 | -0.17 | 2.77 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-4.06
Avg. EPS Est. Current Quarter
-3
Avg. EPS Est. Next Quarter
-2.85
Insider Transactions
Institutional Transactions
-0.17
Beta
1.52
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
23
Growth Score
31
Sentiment Score
95
Actual DrawDown %
98.6
Max Drawdown 5-Year %
-99.6
Target Price
45
P/E
Forward P/E
PEG
P/S
35.83
P/B
1.14
P/Free Cash Flow
EPS
-28.01
Average EPS Est. Cur. Y
-12.15
EPS Next Y. (Est.)
-12
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-9438.49
Relative Volume
1.91
Return on Equity vs Sector %
-329.4
Return on Equity vs Industry %
-314.2
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-3.75
EBIT Estimation
◆
CODX
Healthcare
$5.07
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
16/20
Pullback
0/25
Volume
3/15
Valuation
12/20
TP/AR
4/10
Options
0/10
RSI
81.1
Range 1M
98.5%
Sup Dist
42.4%
🚀
Momentum Growth
Ride accelerating trends
WEAK
Momentum
15/25
Growth
7/30
Estimates
6/20
Inst/Vol
6/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
8.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+787.6% upside
Quality
2/30
Valuation
16/30
Growth
7/25
Stability
6/10
LT Trend
3/5
Upside
+787.6%
Quality
23
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Medical Devices
Employees: 115
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
CODX
Latest News
—
Caricamento notizie per CODX…
stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today
news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance
stock history CODX – Co-Diagnostics, Inc. invest stock market
stock prices CODX premarket after hours
ticker CODX fair value insiders trading